Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS 2a”

183 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 183 results

Very early researchLooking for participantsNCT06464367
What this trial is testing

Mechanistic Studies of Psilocybin in Headache Disorders

Who this might be right for
Migraine
Yale University 50
Early research (Phase 1)Enrolling By InvitationNCT06344026
What this trial is testing

Phase 1/2a Study of ANPD001 in Parkinson Disease

Who this might be right for
Parkinson Disease
Aspen Neuroscience 9
Testing effectiveness (Phase 2)Ended earlyNCT04475549
What this trial is testing

Phase 2a Study of IW-6463 in Adults Diagnosed With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)

Who this might be right for
MELAS
Tisento Therapeutics 8
Not applicableStudy completedNCT03754153
What this trial is testing

Binocularly Balanced Viewing Study

Who this might be right for
Amblyopia
Moorfields Eye Hospital NHS Foundation Trust 32
Testing effectiveness (Phase 2)UnknownNCT05194163
What this trial is testing

MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Neurokine Therapeutics 24
Testing effectiveness (Phase 2)Ended earlyNCT02530307
What this trial is testing

HT-3951 vs. Placebo in Stroke Rehabilitation

Who this might be right for
Ischemic Stroke
Dart NeuroScience, LLC 61
Testing effectiveness (Phase 2)Study completedNCT03027388
What this trial is testing

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grades II, III and IVGlioblastoma MultiformeGiant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT05358717
What this trial is testing

Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

Who this might be right for
Huntington Disease
PTC Therapeutics 159
Testing effectiveness (Phase 2)WithdrawnNCT03474263
What this trial is testing

IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Implicit Bioscience
Testing effectiveness (Phase 2)Looking for participantsNCT06602193
What this trial is testing

Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)

Who this might be right for
Parkinson Disease
Denali Therapeutics Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07451613
What this trial is testing

Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Who this might be right for
Huntington Disease
Leslie Thompson 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05834296
What this trial is testing

Study in Subjects With Mild-to-Moderate Alzheimer's Dementia

Who this might be right for
Alzheimer Disease
Alzamend Neuro, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT04184063
What this trial is testing

Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)

Who this might be right for
Progressive Supranuclear PalsyMultiple System Atrophy
EmeraMed 20
Not applicableStudy completedNCT06204575
What this trial is testing

Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkinsonism

Who this might be right for
Atypical ParkinsonismDementia With Lewy BodiesMultiple System Atrophy, MSA
Rambam Health Care Campus 8
Testing effectiveness (Phase 2)Study completedNCT02002819
What this trial is testing

Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability

Who this might be right for
Alzheimer's Disease
University of Minnesota 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06432166
What this trial is testing

2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
MTI Biotech Inc 48
Testing effectiveness (Phase 2)Looking for participantsNCT06329141
What this trial is testing

Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Glaceum 90
Testing effectiveness (Phase 2)Study completedNCT01943305
What this trial is testing

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Who this might be right for
Yellow FeverEncephalitis, Japanese
Singapore General Hospital 84
Testing effectiveness (Phase 2)Study completedNCT02104661
What this trial is testing

Protective Role of Oxcarbazepine in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Queen Mary University of London 30
Testing effectiveness (Phase 2)Study completedNCT04658186
What this trial is testing

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

Who this might be right for
Early-stage Parkinson's Disease
UCB Biopharma SRL 496
Load More Results